NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Edgewise Therapeutics, Inc. Common Stock Share Price Chart

O H L

Edgewise Therapeutics, Inc. Common Stock Performance Overview

Days Range
$45.55Low
$46.40High

Markets Today

Previous Close$46.94
Open$46.30
Volume187,619
Day's Range$45.55 - $46.40
52W Range$13.85 - $48.40
Market Cap$4.93 B

Historical Performance

1M Returns+6.42
3M Returns+27.52
6M Returns+58.10
1Y Returns+202.25
5Y Returns+171.33
10Y ReturnsNA

Edgewise Therapeutics, Inc. Common Stock Fundamentals

Market Cap$4.93 B
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.34
EPS TTM$-1.85
Quarterly Earnings Growth YOYN/A
PB Ratio10.93
EBITDA$-189.32 M
Profit MarginN/A
Market Cap$4.93 B
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.34
EPS TTM$-1.85
Quarterly Earnings Growth YOYN/A
PB Ratio10.93
EBITDA$-189.32 M
Profit MarginN/A

Edgewise Therapeutics, Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$45.96 M-$42.61 M-$46.86 M-$55.98 M-$54.12 M-$61.94 M
EBITDA -$45.45 M-$42.09 M-$46.34 M-$55.45 M-$53.58 M-$61.40 M
Interest Expense $0$0$0$0$0$0
Depreciation $513.00 K$523.00 K$523.00 K$525.00 K$537.00 K$541.00 K
Income Before Tax -$40.80 M-$36.12 M-$40.67 M-$50.22 M-$49.01 M-$57.33 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$40.80 M-$36.12 M-$40.67 M-$50.22 M-$49.01 M-$57.33 M
Net Profit Margin ------

Edgewise Therapeutics, Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $9.00 K$10.00 K$10.00 K$10.00 K$10.00 K$10.00 K
Reserve & Surplus -$418.97 M-$455.29 M-$495.45 M-$545.69 M-$595.64 M-$653.21 M
Non-Current Liabilities $3.56 M$3.37 M$3.17 M$2.98 M$2.78 M$2.57 M
Current Liabilities $21.11 M$20.90 M$21.65 M$27.37 M$22.54 M$19.45 M
Total Liabilities $24.67 M$24.26 M$24.82 M$30.35 M$25.32 M$31.61 M
Fixed Assets $8.99 M$8.60 M$8.13 M$7.83 M$7.40 M$6.89 M
Current Assets $443.18 M$603.25 M$573.90 M$543.38 M$509.79 M$471.52 M
Total Assets $454.39 M$613.33 M$583.47 M$552.60 M$518.52 M$479.69 M

Edgewise Therapeutics, Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$40.80 M-$36.12 M-$40.67 M-$50.22 M-$49.01 M-$57.33 M
Operating Cash Flow -$37.87 M-$32.58 M-$34.78 M-$38.59 M-$42.54 M-$42.47 M
Investing Cash Flow $43.90 M-$162.17 M$35.72 M$49.76 M$2.43 M$78.49 M
Financing Cash Flow $2.22 M$188.23 M$1.66 M$3.98 M$12.17 M$3.09 M
Change in Cash $8.26 M-$6.52 M$2.60 M$15.14 M-$27.94 M$39.11 M

Edgewise Therapeutics, Inc. Common Stock Return Calculator

The Edgewise Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$26,549
Invested Amount$10,000
Est. Returns$16,549
Invest in USA Stock Today

About Edgewise Therapeutics, Inc. Common Stock

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

FAQs

Edgewise Therapeutics, Inc. Common Stock (EWTX) share price as of September 18, 2026 is $45.93. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Edgewise Therapeutics, Inc. Common Stock (EWTX) Share by opening an international trading account with Angel One.
Purchasing Edgewise Therapeutics, Inc. Common Stock (EWTX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Edgewise Therapeutics, Inc. Common Stock (EWTX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Edgewise Therapeutics, Inc. Common Stock (EWTX) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Edgewise Therapeutics, Inc. Common Stock on September 18, 2026, is $4.93 B.
Edgewise Therapeutics, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Edgewise Therapeutics, Inc. Common Stock (EWTX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91